Page 2 - Alkem Labs

Centre may cap trade margins for drugs in stages; companies oppose plans

While the trade margins for branded generics are standardised by trade, the margins vary in the case of unbranded generics

Alkem Lab, Navin Fluorine: Five mid-cap stocks that are likely to gain 10%

The stock that hits a new lifetime high attracts more volumes resulting in higher price levels.

Alkem Labs Q2 net up 14% at Rs 327 cr on robust sales

Consolidated total income of the company stood at Rs 1,888.95 crore

Drug regulator finds Alkem Labs drug substandard, again

It's the third alert to be issued in the past one year for the anti-diabetic drug; but no recall this time

Alkem Labs tumbles on fudging charges

Germany's medical regulator has accused the Mumbai-based firm of data manipulation in some clinical trials

Alkem Labs dips after observations from UK-MHRA

The company said that UK-MHRA has made eight observations following inspection of its Taloja facility